doi.org/10.1016/j.euf.2017.10.016
Review paper

Marketing and Testosterone Treatment in the USA: A Systematic Review

..., Benjamin Davies
41
European Urology Focus4.80
Volume: 3, Issue: 4-5, Pages: 395 - 402
Published: Oct 1, 2017
Abstract
Testosterone replacement therapy (TRT) is currently approved by the Food and Drug Administration only for classic hypogonadism, although off-label indications have resulted in a dramatic expansion in prescriptions in the USA. Marketing may significantly affect prescriber behavior.To systematically review all available evidence on marketing and TRT in the USA.PubMed, Embase, and Scopus were searched up to July 2017 for all relevant publications...
Paper Fields
Paper Details
Title
Marketing and Testosterone Treatment in the USA: A Systematic Review
DOI
doi.org/10.1016/j.euf.2017.10.016
Published Date
Oct 1, 2017
Journal
European Urology Focus
Volume
3
Issue
4-5
Pages
395 - 402
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.